capacity affinity skeletal muscle insulin-mediated glucose uptake noninsulin-dependent diabetic subjects Effects insulin therapy capacity affinity insulin-mediated glucose uptake IMGU whole body leg muscle obese non-insulin-dependent diabetics NIDDM severe hyperglycemia glycohemoglobin GHb lean controls ln obese nondiabetic controls ob Mean SEM weight kg ln ob NIDDM NS obese groups NIDDM wk intensive insulin therapy GHb post therapy pretherapy Insulin min arterial blood glucose mmol/liter clamp technique Leg glucose uptake LGU product femoral arteriovenous glucose difference FAVGd blood flow thermodilution NIDDM rates whole body IMGU LGU levels NIDDM rates whole body IMGU first levels NS LGU NIDDM ob first level insulin therapy NIDDM indistinguishable ob respect body IMGU LGU levels significant correlation percent GHb maximal FAVGd insulin resistance NIDDM obese subjects similar decreases capacity skeletal muscle IMGU differs NIDDM display decrease affinity skeletal muscle IMGU affinity defect degree antecedent glycemic control reversible insulin therapy acquired defect 